News

Some cancer patients may benefit from being treated with “off-label” drugs that are not routinely prescribed for their exact tumor type, according to new research conducted as part of the Drug Rediscovery Protocol. Findings were published in Nature, September 30, 2019.

A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows.

An international research team has identified several novel genetic variants associated with plasma levels of lipid species and cardiovascular disease risk in humans. The study demonstrates that genetic studies focusing on circulating molecular lipid levels over traditional lipid measures can help improve cardiovascular risk prediction and treatment.

Researchers show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

Georgia Tech researchers have developed a test that detects deadly zinc deficiencies in a single drop of blood. The test could be made compact enough so that many fit in an aid worker’s pocket.

Artificial intelligence (AI) appears to detect diseases from medical imaging with similar levels of accuracy as health-care professionals, according to research led by the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

Some of the genes that predict the risk of high cholesterol don't apply to people from Uganda the same as they do in European populations, finds a new UCL-led study.

Researchers from the Icahn School of Medicine at Mount Sinai, led by Kristen Brennand, have dug deeper into the mystery of schizophrenia's genetic component. In a new study published in Nature Genetics, they explore the potential role of expression quantitative trait loci, or eQTLs, that govern the expression of several genes in schizophrenia.

Biological samples can be highly susceptible to changes over time, and degraded samples can produce spurious results in research. To address these concerns, scientists have designed a highly sensitive test that can be used to establish the integrity of blood plasma and serum, the most common biosamples used in medical research.

Research has shown that thousands of differences in DNA between individuals, associated with immune diseases, are linked with the switching-on of a specific subtype of immune cells.